Sandra Baffour

NPI: 1023324928
Total Payments
$718.23
2024 Payments
$383.48
Companies
6
Transactions
11

Payment Breakdown by Category

Food & Beverage$718.23 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $718.23 11 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $249.23 2 $0 (2024)
CSL Behring $235.41 4 $0 (2024)
GlaxoSmithKline, LLC. $125.00 1 $0 (2021)
ABBVIE INC. $48.61 2 $0 (2024)
Janssen Pharmaceuticals, Inc $32.64 1 $0 (2023)
PFIZER INC. $27.34 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $383.48 6 CSL Behring ($235.41)
2023 $84.83 3 Janssen Pharmaceuticals, Inc ($32.64)
2022 $124.92 1 AstraZeneca Pharmaceuticals LP ($124.92)
2021 $125.00 1 GlaxoSmithKline, LLC. ($125.00)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/21/2024 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $23.76 General
Category: ANTI-INFECTIVE
11/18/2024 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $30.58 General
Category: Trauma (Emergency, Injury, Surgery)
05/02/2024 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $155.00 General
Category: Trauma (Emergency, Injury, Surgery)
04/09/2024 CSL Behring Haegarda (Biological) Food and Beverage In-kind items and services $29.35 General
Category: Immunology
04/02/2024 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $20.48 General
Category: Trauma (Emergency, Injury, Surgery)
01/24/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $124.31 General
Category: Cardiovascular and Metabolism
12/05/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $27.34 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/30/2023 ABBVIE INC. AVYCAZ (Drug) Food and Beverage In-kind items and services $24.85 General
Category: ANTI-INFECTIVE
10/06/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $32.64 General
Category: Cardiovascular & Metabolism
10/25/2022 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $124.92 General
Category: Cardiovascular and Metabolism
09/15/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: RESPIRATORY

About Sandra Baffour

Sandra Baffour is a School healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1023324928.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Baffour has received a total of $718.23 in payments from pharmaceutical and medical device companies, with $383.48 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($718.23).

Practice Information

  • Specialty School
  • Location Brooklyn, NY
  • Active Since 08/30/2010
  • Last Updated 08/30/2010
  • Taxonomy Code 163WS0200X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1023324928

Products in Payments

  • LOKELMA (Drug) $249.23
  • Kcentra (Biological) $206.06
  • TRELEGY ELLIPTA (Drug) $125.00
  • AVYCAZ (Drug) $48.61
  • XARELTO (Drug) $32.64
  • Haegarda (Biological) $29.35
  • ELIQUIS (Drug) $27.34

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

School Doctors in Brooklyn